Donald E. Slaughter
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Drug-Induced Hepatotoxicity and Protection
-
- Drug Transport and Resistance Mechanisms
Papers in ⓘ
-
- Pharmacogenetics and Drug Metabolism 4
-
- Ion channel regulation and function 1
- Co-authors
- Robert P. Hanzlik (3 shared papers)Kamlesh P. Vyas (6 shared papers)Lynn M. Gorham (2 shared papers)Byron H. Arison (3 shared papers)Thomayant Prueksaritanont (2 shared papers)Bennett Ma (1 shared paper)Xiaoming Yu (1 shared paper)Lida Liu (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (2 papers)Drug Metabolism and Disposition (2 papers)SLAS DISCOVERY (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Chemical Research in Toxicology (1 paper)
- Partner nations
- United States
In The Last Decade
Donald E. Slaughter
12 papers receiving 559 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 242
- Pharmacology 97
- Oncology 140
- Toxicology 17
- Biochemistry 34
Countries citing papers authored by Donald E. Slaughter
This map shows the geographic impact of Donald E. Slaughter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. Slaughter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. Slaughter more than expected).
Fields of papers citing papers by Donald E. Slaughter
This network shows the impact of papers produced by Donald E. Slaughter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. Slaughter. The network helps show where Donald E. Slaughter may publish in the future.
Co-authors
The 25 scholars most cited alongside Donald E. Slaughter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. | 1997 | 244 |
| 2 | 2003 | 86 | |
| 3 | 1991 | 57 | |
| 4 | Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. | 2001 | 47 |
| 5 | 1999 | 32 | |
| 6 | 1990 | 30 | |
| 7 | 2000 | 27 | |
| 8 | 1993 | 23 | |
| 9 | 2001 | 13 | |
| 10 | 2003 | 11 | |
| 11 | 2000 | 9 | |
| 12 | Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs. | 1998 | 4 |
About Donald E. Slaughter
Donald E. Slaughter is a scholar working on Pharmacology, Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine and Physiology, having authored 12 papers that have together received 583 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Cardiac electrophysiology and arrhythmias (2 papers), Migraine and Headache Studies (2 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers), Cancer Treatment and Pharmacology (1 paper), Ion channel regulation and function (1 paper), Trigeminal Neuralgia and Treatments (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Pharmacology (242 citations), Pharmacology (97 citations), Oncology (140 citations), Toxicology (17 citations) and Biochemistry (34 citations). Donald E. Slaughter has collaborated with scholars based in United States. Frequent co-authors include Robert P. Hanzlik, Kamlesh P. Vyas, Lynn M. Gorham, Byron H. Arison, Thomayant Prueksaritanont, Bennett Ma, Xiaoming Yu, Lida Liu, Magang Shou and A. David Rodrigues. Their work appears in journals such as The Journal of Clinical Pharmacology, Drug Metabolism and Disposition, SLAS DISCOVERY, Bioorganic & Medicinal Chemistry Letters and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.